european end-to-end CDMO company, pharma services
LinkedIn Share

BioProcess International

BioProcess International | September 15–18, 2025 | Boston, MA (USA)

Meet leading Mabion experts at BioProcess International 2025. Learn our cutting-edge solutions for tackling cost & production hurdles, and secure partnerships. Gain the insights and connections to accelerate your journey, improve patient outcomes, and become a disruptive force in the industry.Connect with your industry colleagues from Mabion during our networking lunches, drinks receptions, as well as our famous Biotech Week Boston festival party held at the Boston Museum of Science.

Meet Mabion at BioProcess International 2025 and Let’s Talk Biologics CDMO Solutions!

The BioProcess International 2025 agenda fits perfectly with the services offered by Mabion. From Cell Line Development to Downstream Processing, Clinical and Commercial Scale Biomanufacturing. Such a large scale allows us to support the entire biopharma market.

We hope that, in line with the trend towards diversification in drug development and manufacturing, American companies will be interested in cooperation and expanding their activities in European markets. Cooperation with Mabion guarantees smooth tech transfer and seamless integration with EMA regulatory requirements. We have experience in working with US companies and a proven track record in the development of biological drugs in the EU.

We remain open to the needs of our customers. Details regarding the format and scope of cooperation can be discussed in Boston with:

  • Adam Pietruszkiewicz, Chief Commercial Officer
  • Marty Henehan, VP of Business Development – Head of North America
  • Bartłomiej Czubek, Director of Business Development

Gain the insights and connections to accelerate your biologics journey.

Check out the BioProcess International website for more details about the conference.

Contact us